{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:37:44Z","timestamp":1779910664733,"version":"3.53.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[1998,8]]},"abstract":"<jats:p>\n            <jats:italic>Abstract<\/jats:italic>\n            \u2014An association of increased apoptosis with overactivity of the local angiotensin-converting enzyme has been reported in cells from the left ventricle of adult rats with spontaneous hypertension (SHR). To gain insight into the regulation of cardiac apoptosis in arterial hypertension, we investigated the expression of the proteins Bcl-2 (an inhibitor of apoptosis) and Bax (an inducer of apoptosis) in the left ventricle of 30-week-old normotensive Wistar-Kyoto rats (WKY), SHR, and SHR treated with the angiotensin II type 1 receptor (AT\n            <jats:sub>1<\/jats:sub>\n            ) antagonist losartan (20 mg \u00b7 kg\n            <jats:sup>\u22121<\/jats:sup>\n            \u00b7 d\n            <jats:sup>\u22121<\/jats:sup>\n            ) during 14 weeks before death. The density of apoptotic cells was assessed by direct immunoperoxidase detection of biotin-labeled deoxyuridin nucleotides. The expression of Bcl-2 and Bax was assessed by Western blot analysis. Compared with WKY, untreated SHR exhibited increased (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05) apoptosis, increased (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01) Bax, and similar Bcl-2. The Bcl-2\/Bax ratio (an inverse index of cell susceptibility to apoptosis) was lower (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05) in untreated SHR than in WKY. The chronic administration of losartan was associated with the normalization of apoptosis, Bax expression, and the Bcl-2\/Bax ratio in treated SHR. No changes in the expression of Bcl-2 were observed in these rats after treatment. No significant changes in the apoptotic density were observed between treated SHR with normal blood pressure and treated SHR with abnormally high blood pressure at the end of the treatment period. These results suggest that an association exists between increased apoptosis and overexpression of Bax oncoprotein in cells from the left ventricle of adult SHR. Chronic blockade of AT\n            <jats:sub>1<\/jats:sub>\n            receptors prevents Bax overexpression and normalizes apoptosis in the left ventricle of SHR independently of its hemodynamic effect. On the basis of our findings, it can be proposed that the interaction of angiotensin II with its AT\n            <jats:sub>1<\/jats:sub>\n            receptors may participate in the stimulation of Bax protein, which in turn renders cells from the left ventricle of SHR more susceptible to apoptosis.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.32.2.280","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:53:46Z","timestamp":1339462426000},"page":"280-286","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":91,"title":["Overexpression of Bax Protein and Enhanced Apoptosis in the Left Ventricle of Spontaneously Hypertensive Rats"],"prefix":"10.1161","volume":"32","author":[{"given":"Mari\u0301a Antonia","family":"Fortun\u0303o","sequence":"first","affiliation":[{"name":"From the Vascular Pathophysiology Unit, School of Medicine, University of Navarra, Pamplona (M.A.F., S.R., J.C.E., J.D.), and the Department of Medicine, School of Medicine, University of Zaragoza, Zaragoza (J.D.), Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Ravassa","sequence":"additional","affiliation":[{"name":"From the Vascular Pathophysiology Unit, School of Medicine, University of Navarra, Pamplona (M.A.F., S.R., J.C.E., J.D.), and the Department of Medicine, School of Medicine, University of Zaragoza, Zaragoza (J.D.), Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Etayo","sequence":"additional","affiliation":[{"name":"From the Vascular Pathophysiology Unit, School of Medicine, University of Navarra, Pamplona (M.A.F., S.R., J.C.E., J.D.), and the Department of Medicine, School of Medicine, University of Zaragoza, Zaragoza (J.D.), Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Di\u0301ez","sequence":"additional","affiliation":[{"name":"From the Vascular Pathophysiology Unit, School of Medicine, University of Navarra, Pamplona (M.A.F., S.R., J.C.E., J.D.), and the Department of Medicine, School of Medicine, University of Zaragoza, Zaragoza (J.D.), Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","first-page":"199","volume":"9","year":"1994","unstructured":"Bennett MR, Evan GI. The molecular basis of apoptosis. Heart Failure. 1994;9:199\u2013212.","journal-title":"Heart Failure"},{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711530404"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.124.1.1"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/348334a0"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90509-O"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0697-614"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90188-0"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.26.4.642"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.30.5.1029"},{"key":"e_1_3_1_10_2","first-page":"H2313","volume":"272","year":"1997","unstructured":"Li Z, Bing OHL, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol. 1997;272:H2313\u2013H2319.","journal-title":". Am J Physiol"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118747"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1996.0333"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1997.3477"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1997.3604"},{"key":"e_1_3_1_15_2","unstructured":"Lovenberg W. Techniques for the measurement of blood pressure. Hypertension. 1987;9(suppl I):I-5\u2013I-6."},{"key":"e_1_3_1_16_2","first-page":"559","volume":"42","year":"1980","unstructured":"Olivetti G, Anversa P, Melissari M, Loud AV. Morphometry of medial hypertrophy in the rat thoracic aorta. Lab Invest. 1980;42:559\u2013565.","journal-title":"Lab Invest"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(95)00120-E"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.119.3.493"},{"key":"e_1_3_1_19_2","first-page":"1325","volume":"146","year":"1995","unstructured":"Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Koike M, Nomura M, Jie T, Ito K. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol. 1995;146:1325\u20131331.","journal-title":"Am J Pathol"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711770415"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118280"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.29.3.776"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.94.7.1506"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.96.5.1580"},{"key":"e_1_3_1_25_2","first-page":"1799","volume":"9","year":"1994","unstructured":"Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Lieberman DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799\u20131805.","journal-title":"Oncogene"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90412-3"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)31689-7"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90457-2"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.72.6.8495545"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1994.1098"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)80066-N"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8235659"},{"key":"e_1_3_1_33_2","first-page":"771","volume":"73","year":"1995","unstructured":"Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, Anversa P. Myocyte nuclear mitotic division and programmed cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest. 1995;73:771\u2013778.","journal-title":"Lab Invest"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.91.1.161"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/28.8.1199"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610173351603"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704173361603"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1994.1115"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","unstructured":"deBlois D Tea BS Dam TV Tremblay J Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension. 1997;29(pt 2):340\u2013349.","DOI":"10.1161\/01.HYP.29.1.340"},{"key":"e_1_3_1_40_2","unstructured":"Toger CA Francis GS. Use of angiotensin-converting enzyme inhibitors in the treatment and prevention of congestive heart failure. In: Messerli FH ed. Cardiovascular Drug Therapy. 2nd ed. Philadelphia Pa: WB Saunders; 1996:711\u2013717."},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)01187-2"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.32.2.280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T17:20:23Z","timestamp":1715534423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.32.2.280"}},"subtitle":["Effects of AT\n            <sub>1<\/sub>\n            Blockade With Losartan"],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1161\/01.HYP.32.2.280"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.32.2.280","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]},"assertion":[{"value":"1997-12-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-04-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}